Med Business World

Your source for healthcare business

Sushant Kumar, CEO of Genefitletics, discussing the future of personalized healthcare
Authored Articles

Genefitletics: Pioneering the Microbiome Frontier – An Exclusive Interview with Founder Sushant Kumar

On World Health Day, we take the opportunity to explore the rapidly evolving landscape of the healthcare industry, focusing on groundbreaking innovations that are transforming the way we approach health and well-being. Personalized medicine and biotechnology have experienced significant advancements in recent years, paving the way for new, targeted treatments and diagnostics that cater to individual needs.

One company that has emerged as a leader in this space is Genefitletics, an Indian biotech firm that combines systems biology and artificial intelligence to study the human microbiome and its role in various chronic diseases, recurrent infections, infertility, preterm births, and cancer. By closing the gap between scientific research and practical healthcare applications, Genefitletics is redefining what’s possible in the realm of personalized medicine.

To gain a deeper understanding of their trailblazing work and their aspirations for the future of healthcare, we had an insightful conversation with Mr. Sushant Kumar, the Founder & CEO of Genefitletics. In this exclusive interview, Mr. Kumar shares his personal motivation for founding the company, the unique approach Genefitletics takes in the biotech industry, and the importance of prioritizing our health and well-being in today’s fast-paced world.

An Exclusive Interview with Mr. Sushant Kumar, Founder & CEO of Genefitletics

Q: Can you give us a brief overview of Genefitletics and the motivation behind its founding?

Genefitletics was born from my personal experiences with the illnesses of my loved ones. Despite the modern healthcare system’s advanced diagnostics and smart AI technologies, it failed to cure my family members. I became determined to understand why chronic diseases, cancer, infertility, preterm births, and other health issues continued to rise. My research led me to the crucial role of microbes in our body, which make up 57% of our cells. Genefitletics was founded to pioneer the application of microbes to improve human health, making us India’s first and only biotech company bridging the gap between scientific research and human health.

Q: How does the combination of systems biology and artificial intelligence set Genefitletics apart from other biotech companies in the industry?

The key differentiator between Genefitletics and other biotech companies is our focus on “Gene Expression.” While many microbiome companies in precision medicine concentrate on static genes, we prioritize the ever-evolving microbial gene expression. By working at the intersection of system biology and AI, Genefitletics can quantify, measure, and track biological pathways, decoding microbial metabolites’ production, suppressed biological functions, and precision interventions to restore the body to a state of balance.

Q: What are some of the most significant breakthroughs your team has achieved in the development of diagnostic and therapeutic approaches for chronic diseases, recurrent infections, infertility, preterm births, and cancer?

We have designed, launched, and commercialized Asia’s only gut and vaginal microbiome tests that study and analyze human microbial functions at the molecular and cellular level, empowering people to reclaim control of their health. Over the last two years, we have helped more than 200 people overcome a variety of health challenges, including multiple chronic conditions, autoimmune disorders, anxiety, IBD, hypertension, cholesterol, depression, food intolerances, eating disorders, acne, eczema, and more.

Q: How do you envision the future of personalized medicine, and how does Genefitletics plan to contribute to that vision?

Personalized medicine demands greater precision, which will be achieved through the combination of modern and alternative medicine, ultimately personalizing food as medicine. Our vision is simple: unlike current practices that prescribe one drug for each symptom, we believe there is only one drug for each individual – nutrition tailored to an individual’s unique biology.

Q: Can you share some success stories from individuals who have benefited from Genefitletics’ innovative approaches?

Genefitletics’ innovative solutions have empowered many people to regain control of their health. Some of the success stories include:

  • A 29-year-old female was struggling with postpartum depression, weight gain, and dry skin. After completing our program, she regained her energy, lost 7 kgs, resolved her hair fall issue, and experienced glowing skin once more.
  • A 26-year-old female suffered from an autoimmune disorder called Granulomatosis with polyangiitis (GPA) and had a history of lung cavities, chronic fatigue, anxiety, panic attacks, digestive issues, and ear inflammation. After completing our program for 8 months, she saw improvements in her energy levels, sugar cravings, stress, and digestive issues improved by 70%.
  • A 70-year-old man was dealing with eczema issues and had iron deficiency. Our analysis revealed he lacked a specific microbe responsible for metabolizing iron, causing the iron supplements to accumulate in his skin and trigger eczema. Our recommendations helped him resolve his skin issues within three months.

Q: How does Genefitletics ensure the privacy and security of its customers’ molecular information?

We implement a double-layer security protection to encrypt and store data safely on our servers. Customers’ identities are protected through unique identification numbers, which are inaccessible even to our organization’s members. We are also working on implementing blockchain technology to further secure data.

Q: What is your perspective on the ethical considerations surrounding the use of AI in healthcare and biotechnology?

Ethical considerations should include regulating access to and unveiling data points that can help deep learning models predict diseases in individuals. Currently, there is no regulation for genomics and microbiome data regarding storage, safety, and distribution to third parties. Given the Indian Government’s recent genome sequencing project initiative, ensuring data privacy and usage protection should be a top priority.

Q: What role do you see for public policy and regulatory frameworks in facilitating or hindering the growth and innovation of companies like Genefitletics?

The government should adopt multifaceted approaches to support the growth of innovative companies like Genefitletics, including subsidizing genome and microbiome testing for the general public, incorporating microbiome testing as part of preventive health measures, offering tax holidays for setting up microbiome sequencing facilities, covering microbiome testing under health insurance, and encouraging financial institutions to extend project financing to new-age deep tech and biotechnology companies.

Q: How do you maintain a strong company culture that fosters curiosity, innovation, and collaboration among your diverse team of experts?

We believe in delegation and empowerment, granting our team the freedom to explore and develop disruptive ideas, all while keeping the central focus on improving human health.

Q: Lastly, in light of World Health Day, what message would you like to share with our readers about the importance of prioritizing their health and well-being?

Our modern lifestyle, combined with stress, environmental toxins, and processed foods, has led to increased lifespans but diminished health spans. Make the right choices for your life and prioritize your mental peace and health over accumulating wealth. The first step towards better health starts with making the right nutrition choices.

As we celebrate World Health Day, the insights shared by Mr. Sushant Kumar offer a powerful reminder of the importance of prioritizing our health and well-being. Innovative companies like Genefitletics are at the forefront of shaping the future of personalized medicine, leveraging the power of biotechnology and artificial intelligence to deliver targeted and precise healthcare solutions.

It’s essential for individuals, industry leaders, and policymakers to work together in order to foster a healthcare environment that not only extends our lifespans but also improves our overall quality of life. On World Health Day, let’s take a moment to recognize the advancements in healthcare and commit to making informed choices about our own health and the well-being of our communities.



Your email address will not be published. Required fields are marked *